Neuropsychological evaluation and parental assessment of behavioral and motor difficulties in children with neurofibromatosis type 1
Introduction
Neurofibromatosis 1 (NF1) is a common autosomal dominant disorder with a prevalence of 1 in 4000–5000, and an incidence of 1 in 2000–3000 births (Evans et al., 2010). Approximately half of NF1 cases are inherited and half are caused by sporadic de novo heterozygous mutation of the NF1 gene at chromosome 17q11.2. This multisystem disorder is characterized by large inter and intrafamilial clinical variability and uncertain prognosis (Ferner, 2010). Clinical phenotype may also change substantially with age, because patients with NF1 can develop one or more multisystemic complications during their life, resulting in the characteristically high morbidity and significantly increased mortality of this disease. Common manifestations are café au lait macules, axillary and/or inguinal freckling, neurofibromas and Lisch nodules. The complications of NF1 involve different bodily systems such as the skin, eyes, bone, nervous system, cardiovascular system, respiratory system or gastrointestinal system (Ferner, 2010). NF1 is currently diagnosed according to the clinical criteria of the National Institute of Health Consensus Conference statement (NIH, 1988). Cognitive problems and learning difficulties are very frequent in children with NF1 and are the most common complication affecting quality of life (Hyman, Shores, & North, 2005). Patients with NF1 usually have an IQ in the low to average range, but about 6% have an intellectual disability (Ferner et al., 1996, Hyman et al., 2005, Hyman et al., 2006). Particular cognitive functions may be impaired (Lehtonen et al., 2013, Levine et al., 2006), especially visuospatial skills (Hyman et al., 2003, Schrimsher et al., 2003), motor skills and coordination (Hyman et al., 2005), complex psychomotor skills (Descheemaeker, Ghesquière, Symons, Fryns, & Legius, 2005), attention (Gilboa et al., 2011, Hyman et al., 2005, North et al., 2002, Payne et al., 2011), and executive functions (Hyman et al., 2005, Payne et al., 2011).
Learning disabilities and behavioral problems are often reported by the parents of children with NF1 (Lehtonen et al., 2013, North et al., 1997). According to many reports, about 50% of children with NF1 have learning disabilities (Descheemaeker et al., 2005, Hyman et al., 2005), and approximately 30 to 50% meet the diagnostic criteria of attention deficit hyperactivity disorder (ADHD) (Clements-Stephens et al., 2008, Cutting and Levine, 2010, Hyman et al., 2005, Johnson et al., 1999, Kayl and Moore, 2000, Koth et al., 2000, Levine et al., 2006, Roy et al., 2010). ADHD is a major risk factor for poor social skills and behavioral problems in children with NF1 (Barton & North, 2004).
The diagnosis of ADHD in children with NF1 is often based on interviews and questionnaires completed by parents and teachers, such as the Conners’ Parent Rating Scale (Conners, Sitarenios, Parker, & Epstein, 1998), or the Child Behavior Checklist (CBCL; Achenbach, 1991). Many children and adolescents with NF1 have clinically significant scores on various Conners’ subscales measuring inattention, cognitive problems, hyperactivity, or ADHD criteria (Gilboa et al., 2011). Studies using the CBCL report similar findings (Barton and North, 2004, Dilts et al., 1996, Johnson et al., 1999, Noll et al., 2007). Children with NF1 also show clinically significant scores on the Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al., 2000a, Gioia et al., 2000b), as rated by parents and teachers (Gilboa et al., 2011, Gilboa et al., 2014, Payne et al., 2011). However, the results of particular neuropsychological tests of attention or executive functions and parental reports of inattention/hyperactivity (Conners Third Edition-Parent, Conners, 2008) or executive functions (BRIEF) are poorly correlated (Isenberg et al., 2012, Payne et al., 2011).
Several questionnaires, not specific to NF1, have shown that Quality of Life (QoL) is strongly affected in patients with NF1 (Graf et al., 2006, Oostenbrink et al., 2007, Page et al., 2006, Wolkenstein et al., 2001). QoL is worse in patients with NF1 than in those with other chronic diseases, such as asthma, because of complications, especially orthopedic manifestations, learning disabilities and plexiform neurofibromas (Wolkenstein et al., 2009). Parents are more pessimistic than patients themselves (Oostenbrink et al., 2007, Wolkenstein et al., 2009), and pessimism is less common in familial than in sporadic NF1 (Wolkenstein et al., 2009).
It remains unclear how behavioral difficulties, QoL and cognitive deficits are related in children with NF1. Furthermore, studies report inconsistent findings regarding the relationship between cognitive–behavioral difficulties, clinical manifestations and the transmission of NF1 (sporadic versus familial) (Barton and North, 2004, Ferner et al., 1996, Hyman et al., 2005, Wolkenstein et al., 2009). Here, we used questionnaires completed by the parents of children or adolescents with NF1 to evaluate cognitive and behavioral difficulties (Conners’ Parent Rating Scale, CBCL, and BRIEF). We also used quality of life scales (Impact of Childhood Illness Scale, Short QoL Scale) and assessed parents’ concerns about their child's learning and cognitive difficulties, and examined relationship between these factors and cognitive deficits evaluated by individual neuropsychological assessment.
Specific aims were: to evaluate the neuropsychological profile of children with NF1 and to confirm that they have specific deficits in visuospatial skills, attention, and academic skills (reading), despite overall preserved intellectual efficiency; to describe behavioral difficulties as assessed by questionnaires completed by parents; to search for clinical factors associated with neuropsychological and behavioral difficulties; to compare the neuropsychological and behavioral profile between the sporadic and the familial transmission; and finally, to examine correlations between the results of behavioral questionnaires, behavioral difficulties and neuropsychological assessment.
Section snippets
Participants
Children with NF1 were recruited from the Neurofibromatosis Referral Center at Trousseau Pediatric Hospital in Paris between December 2012 and June 2014. Inclusion criteria were: children and adolescents diagnosed with NF1 according to clinical criteria (NIH, 1988), aged between 5 and 18 years and French speaking. There were no exclusion criteria in our study. Informed consent was obtained from the parents of the participants and the children themselves before the neuropsychological assessment.
Clinical, school and rehabilitation data
Almost all patients (more than 95%) had café-au-lait spots and freckling. Lisch nodules were present in 46% of children, neurofibromas in 40% and plexiform neurofibromas in 20%. Twenty children (26%) had a bone complication such as scoliosis. MRI detected an optic pathway glioma (without a severe visual deficit) in four patients (5%) and another tumor of the central nervous system in five (6%). Two children (3%) had epileptic seizures (Table 1).
Table 2 shows the school situation and the
Discussion
The present study shows specific visuospatial and motor difficulties in children with NF1, better verbal IQ than performance IQ, frequent behavioral difficulties reported by parents, and only weak correlation between objectively assessed neuropsychological difficulties and parental report.
The frequency of clinical manifestations in this study is consistent with the literature (Pinson & Wolkenstein, 2005). The proportion of familial transmissions (36%) was similar to that reported by Barton and
Conclusions
Predominance of visuospatial and motor difficulties in children with NF should be considered in rehabilitation programs aiming to reduce the learning and school difficulties of these children. Parental reports of specific difficulties should be considered independently of clinical severity and neuropsychological tests.
Acknowledgement
We would like to thank the children and their parents for their participation.
References (70)
- et al.
Complications de la neurofibromatose de type 1 chez l’enfant: À propos d’une série de 100 cas
Archives de Pédiatrie
(2006) - et al.
Visuospatial processing in children with neurofibromatosis type 1
Neuropsychologia
(2008) - et al.
Intellectual impairment in neurofibromatosis 1
Journal of the Neurological Sciences
(1996) - et al.
Using a virtual classroom environment to describe the attention deficits profile of children with neurofibromatosis type 1
Research in Developmental Disabilities
(2011) - et al.
Quality of life and psychological adjustment in children with neurofibromatosis type 1
The Journal of Pediatrics
(2006) - et al.
Neurofibromatosis type 1: The cognitive phenotype
The Journal of Pediatrics
(1994) - et al.
Social and emotional problems in children with Neurofibromatosis type 1: Evidence and proposed interventions
The Journal of Pediatrics
(1999) - et al.
La neurofibromatose de type 1 ou maladie de Von Recklinghausen
La Revue de Médecine Interne
(2005) Manual for the child behavior checklist/4–18 and 1991 profile
(1991)- et al.
The manual for the ASEBA scholl-age forms and profiles
(2001)
Social skills of children with neurofibromatosis type 1
Developmental Medicine & Child Neurology
Judgment of line orientation
Learning disability in children with neurofibromatosis
Journal of Learning Disabilities
Echelle d’évaluation rapide de l’écriture chez l’enfant (BHK, adaptation française)
The Revised Conners’ Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity
Journal of Abnormal Child Psychology
Conners
How children with neurofibromatosis type 1 differ from “typical” learning disabled clinic attenders: Nonverbal learning disabilities revisited
Developmental Neuropsychology
Cognitive profile of children with neurofibromatosis and reading disabilities
Child Neuropsychology
Behavioral, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children
Journal of Intellectual Disabilities Research
Children and adolescents with neurofibromatosis 1: A behavioural phenotype
Journal of Developmental and Behavioral Pediatrics
Neurofibromatosis: Implications for learning and behaviour
Journal of Developmental and behavioural Pediatrics
Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service
American Journal of Medical Genetics, Part A
Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities
Neurology
The neurofibromatoses
Practical Neurology
Studies of age-correlated features of cognitive–behavioral development in children and adolescents with genetic disorders
American Journal of Medicine Genetics
The Purdue Pegboard: Normative data on 1334 school children
Journal of Clinical Child Psychology
Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study
Developmental Medicine and Child Neurology
Application of the international classification of functioning, disability and health in children with neurofibromatosis type 1: A review
Developmental Medicine and Child Neurology
Is there a relationship between executive functions and academic success in children with neurofibromatosis type 1?
Neuropsychological Rehabilitation
Test review: Behavior rating inventory of executive function (BRIEF)
Child Neuropsychology
Inventaire pour l’évaluation du comportement de la fonction exécutive version parents
Normative data on revised Conners Parent and Teacher Rating Scales
Journal of Abnormal Child Psychology
Escala de calidad de vida del nino con epilepsia (CAVE)
Review of Neurology (Spain)
The quality of life of children with chronic epilepsy and their families: Preliminary findings with a new assessment measure
Developmental Medicine and Child Neurology
Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1
Neurology
Cited by (13)
Motor dysfunction in NF1: Mediated by attention deficit or inherent to the disorder?
2018, European Journal of Paediatric NeurologyLongitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1
2022, Journal of Pediatric PsychologyEvolving molecular biology, targeted therapeutics and neurocognitive deficits in neurofibromatosis 1
2021, Neurofibromatosis Type 1: Diagnosis, Prevalence and Quality of Life